PAVmed Inc. — Form 8-K
Filed October 22, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
PAVmed Inc. (market cap ~$7.0M) filed an 8-K on 2026-10-21 reporting entry into a material definitive agreement (Item 1.01) and material modifications to security holder rights (Item 3.03). The filing does not disclose the counterparty identity, dollar amounts, term dates, or specific nature of the agreement or rights modifications in the accessible text provided.
Why this rating
Material agreement announced but zero concrete financial/commercial terms disclosed; cannot assess magnitude. Standard 8-K disclosure structure with exhibits, but substance unavailable.
Extracted items
- 1.01 material agreement
- 3.03
- 9.01 exhibits
See more from October 22, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.